Literature DB >> 28690456

Diagnosis of Nonalcoholic Steatohepatitis Without Liver Biopsy.

Beatrice L Madrazo1.   

Abstract

Entities:  

Year:  2017        PMID： 28690456      PMCID： PMC5495045     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  7 in total

Review 1.  Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy.

Authors:  Scott B Reeder; Irene Cruite; Gavin Hamilton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2011-09-16       Impact factor: 4.813

2.  Using a 3% Proton Density Fat Fraction as a Cut-Off Value Increases Sensitivity of Detection of Hepatic Steatosis, Based on Results From Histopathology Analysis.

Authors:  Patrik Nasr; Mikael F Forsgren; Simone Ignatova; Nils Dahlström; Gunnar Cedersund; Olof Dahlqvist Leinhard; Bengt Norén; Mattias Ekstedt; Peter Lundberg; Stergios Kechagias
Journal:  Gastroenterology       Date:  2017-03-09       Impact factor: 22.682

Review 3.  Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease.

Authors:  Laurent Castera
Journal:  Semin Liver Dis       Date:  2015-09-17       Impact factor: 6.115

Review 4.  Radiologic evaluation of nonalcoholic fatty liver disease.

Authors:  Seung Soo Lee; Seong Ho Park
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

5.  Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.

Authors:  Mazen Noureddin; Jessica Lam; Michael R Peterson; Michael Middleton; Gavin Hamilton; Thuy-Anh Le; Ricki Bettencourt; Chris Changchien; David A Brenner; Claude Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2013-10-17       Impact factor: 17.425

6.  Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.

Authors:  Jeffrey Cui; Elhamy Heba; Carolyn Hernandez; William Haufe; Jonathan Hooker; Michael P Andre; Mark A Valasek; Hamed Aryafar; Claude B Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2015-12-18       Impact factor: 17.425

Review 7.  MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice.

Authors:  Parambir S Dulai; Claude B Sirlin; Rohit Loomba
Journal:  J Hepatol       Date:  2016-06-14       Impact factor: 25.083
  7 in total
  3 in total

Review 1.  Drug-Induced Steatosis and Steatohepatitis: The Search for Novel Serum Biomarkers Among Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.

Authors:  Lauren Pavlik; Arie Regev; Paul A Ardayfio; Naga P Chalasani
Journal:  Drug Saf       Date:  2019-06       Impact factor: 5.606

Review 2.  Strategies to Diagnose Nonalcoholic Steatohepatitis: A Novel Approach to Take Advantage of Pharmacokinetic Alterations.

Authors:  Solène Marie; David K K Tripp; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2021-09-16       Impact factor: 3.579

Review 3.  A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH).

Authors:  Manca Povsic; On Yee Wong; Richard Perry; Juliana Bottomley
Journal:  Adv Ther       Date:  2019-05-07       Impact factor: 3.845
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.